EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structural and functional characterization of VapBC52 toxin–antitoxin system from Mycobacterium tuberculosis

Manisha Singh, Charandeep Singh, Akshay V Nair, Imran Ahmad, Arun Sharma, Munmun Bhasin, Vikas Jain iD, Ramandeep Singh iD, Krishan Gopal Thakur iD

Nucleic Acids Research · 08.06.2026 · 54 (11)

DOI: 10.1093/nar/gkag611 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 17.06.2026. Verfasst von Manisha Singh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Tuberculosis Research, Tuberculosis Research Laboratory, BRIC-Translational Health Science and Technology Institute, Faridabad-Gurugram Ex…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Toxin-Antitoxin Systems, Bacterial Proteins, Bacterial Toxins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Council of Scientific and Industrial Research, DBT-Wellcome Trust India, Anusandhan National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycobacterium tuberculosis (Mtb) encodes a huge repertoire of toxin–antitoxin (TA) systems, many of which remain uncharacterized. Here, we report the crystal structures of the VapC52 toxin and VapBC52 TA complex at a resolution of 2.6 and 3.2 Å, respectively. We show that VapC52 adopts a unique open dimeric conformation and inhibits mycobacterial growth by cleaving tRNA at the variable or anticodon loop region. Structure reveals that VapB52 adopts a distinct structural architecture and binds VapC52 with a 1:2 stoichiometry, respectively. Interestingly, binding of ssDNA activates VapB52 peptidase domain, resulting in auto-cleavage of VapB52 N-terminal domain which is critical for VapBC complex formation and neutralization. In addition to VapB52, co-expression of several other non-cognate VapB antitoxins abrogates the growth inhibition associated with VapC52 overexpression in Mycobacterium smegmatis (Msm) suggesting crosstalk among VapBC TA systems. Further, we demonstrate that the vapBC52 locus is dispensable for in vitro growth but essential for Mtb intracellular growth in macrophages and guinea pigs. Notably, VapC52 also cleaves mycobacteriophage D29 encoded tRNAs and confers resistance to phage infection in Msm. Taken together, we show that VapBC52 adopts a unique structural architecture, plays role in pathogenesis, and is possibly involved in mycobacterial antiphage defense mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisToxin-Antitoxin SystemsBacterial ProteinsBacterial ToxinsAnimalsModels, MolecularRNA, TransferGuinea PigsCrystallography, X-RayMycobacterium smegmatisMacrophagesDNA, Single-StrandedDNA-Binding ProteinsMembrane Glycoproteins

Substanzen

Bacterial ProteinsBacterial ToxinsRNA, TransferVapB protein, BacteriaDNA, Single-StrandedDNA-Binding ProteinsMembrane Glycoproteins

Autor:innen und Institutionen

  • Centre for Tuberculosis Research, Tuberculosis Research Laboratory, BRIC-Translational Health Science and Technology Institute, Faridabad-Gurugram Expressway, Faridabad, Haryana 121001, India.
  • Structural Biology Laboratory, CSIR-Institute of Microbial Technology, Sector 39A, Chandigarh 160036, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
  • Microbiology and Molecular Biology Laboratory, Department of Biological Sciences, Indian Institute of Science Education and Research (IISER) Bhopal, Madhya Pradesh 462066, India.
  • Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.
  • Molecular Biophysics Unit, Indian Institute of Science, Bangalore 560012, India.

ORCID-Profile: Vikas Jain, Ramandeep Singh, Krishan Gopal Thakur

Förderung

  • Council of Scientific and Industrial Research
  • DBT-Wellcome Trust India
  • Anusandhan National Research Foundation
  • Centre of Excellence for Anti-Viral and Anti-Bacterial Drug Discovery and Development
  • Department of Pharmaceuticals, Government of India, New Delhi

Zitieren

APA

Singh, M., Singh, C., Nair, A. V., Ahmad, I., Sharma, A., Bhasin, M., Jain, V., Singh, R., & Thakur, K. G. (2026). Structural and functional characterization of VapBC52 toxin–antitoxin system from Mycobacterium tuberculosis. Nucleic Acids Research, 54(11). https://doi.org/10.1093/nar/gkag611

Vancouver

Singh M, Singh C, Nair AV, Ahmad I, Sharma A, Bhasin M, et al. Structural and functional characterization of VapBC52 toxin–antitoxin system from Mycobacterium tuberculosis. Nucleic Acids Research. 2026;54(11). doi:10.1093/nar/gkag611

BibTeX
@article{Singh2026,
  author = {Singh, Manisha and Singh, Charandeep and Nair, Akshay V and Ahmad, Imran and Sharma, Arun and Bhasin, Munmun and Jain, Vikas and Singh, Ramandeep and Thakur, Krishan Gopal},
  title = {Structural and functional characterization of VapBC52 toxin–antitoxin system from Mycobacterium tuberculosis},
  journal = {Nucleic Acids Research},
  year = {2026},
  volume = {54},
  number = {11},
  doi = {10.1093/nar/gkag611}
}
Kostenlos starten →